Nonprofit screen
Screen a listOxfendazole Development Group
Can you give?
Listed with the IRS. Every screen came back clear.
A 501(c)(3) on Publication 78 and the IRS master file.
- IRS nonprofit listing
- No issue
- Revocation
- None
- IRS files
- Agree
- Sanctions
- No match
- IRS bulletin
- No notice
- California
- Registered
- Charity type
- 509(a)(1)
$9krevenue
FY2025 · −99% in 3 yrs4 of 4years filed
’22’23’24’25
Revenue and spendingRevenueSpendingDeficit
Against similar nonprofits FY2025
Operating margin−2534.9%
Months of reserve5.3mo
Revenue growth (annualized)−82.9%
Middle half of peersMedianOxfendazole Development Group
Where the money goes FY2025 · $227k spent
Programs$225k99%Management and general$1k1%990 FY2025 · Part IX line 25
Worth checking1
Deficits in 3 of the last 3 years
−$546k in FY2023, −$829k in FY2024 and −$218k in FY2025. Cash covers 5.3 months, under the peer median of 15.9.
990 Part I and balance sheetIn its favor
None found in the filings.
4funders
$567ka year, last 3 years
94%from its largest funder
Funder’17’18’19’20’21’22’23Johns Hopkins UniversityStopped after FY2018$58k$103k–Effective Ventures Foundation USA IncOn and off$101kDonor-advised giftsDonors not disclosed$41$41$1.6M$43
FundedThrough a donor-advised fundStopped